OP-5244 is a potent and orally active inhibitor of CD73, with an IC 50 of 0.25 nM. OP-5244 reverses immunosuppression through blocking of adenosine production, and has the potential for the cancer research.
性状
Solid
IC50 & Target[1][2]
IC50: 0.25 nM (CD73)
体外研究(In Vitro)
OP-5244 inhibits the production of adenosine (ADO), with an EC50 of 0.79±0.38 nM in H1568 (NSCLC) cells.OP-5244 inhibits AMP hydrolysis to ADO in peripheral blood derived CD8 T cells with an EC50 of 0.22 nM.OP-5244 (4.1-1000 nM; 96 h) rescues AMP-suppressed CD8 T cells proliferation and cytokine production.OP-5244 (0.01 nM-10 μM) inhibits ADO production completely in human and murine cancer cell lines (H1568 and EMT6, respectively). has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
OP-5244 (15 mg/kg/day; s.c. for 13 d) exhibits anti-tumor effects as a single agent as shown by the tumor growth inhibition in mice.
OP-5244 (150 mg/kg; p.o. twice daily for 16 d) increases CD8 T cells infiltration and reverses immunosuppression in mice.
OP-5244 (0.2 mg/kg; i.v.) exhibits terminal elimination half-lives (rat 8.5, dog 0.82, cyno 4.6 h) due to moderate plasma clearance (rat 0.18, dog 1.22, cyno 0.05 L/kg/h) and low steady-state volume of distribution (rat 0.22, dog 0.29, cyno 0.10 L/kg/h).
OP-5244 (10 mg/kg; p.o.) exhibits C max (rat 0.82, dog 1.25, cyno 1.72 μM) and AUC (rat 1.96, dog 1.75, cyno 14.2 μM?h) . has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
4°C, sealed storage, away from moisture and light In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
参考文献
[1]. Du X, et, al. Orally Bioavailable Small Molecule CD73 Inhibitor (OP-5244) Reverses Immunosuppression Through Blockade of Adenosine Production. J Med Chem. 2020 Aug 31.
溶解度数据
In Vitro: DMSO : 250 mg/mL (464.78 mM; Need ultrasonic)H2O : 100 mg/mL (185.91 mM; Need ultrasonic)配制储备液